Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18959018 | PPG SIGNAL QUALITY EVALUATION METHOD AND APPARATUS AND PPG SIGNAL PROCESSING METHOD AND SYSTEM | November 2024 | April 2025 | Allow | 5 | 0 | 1 | Yes | No |
| 18776706 | CATHETER POSITION TRACKING AND REPRESENTATION USING A DYNAMIC SPRING MODEL AND MOTION EQUATION | July 2024 | June 2025 | Allow | 11 | 2 | 0 | Yes | No |
| 18661494 | SYSTEM TO MONITOR AND MANAGE PATIENT HYDRATION VIA PLETHYSMOGRAPH VARIABILITY INDEX IN RESPONSE TO THE PASSIVE LEG RAISING | May 2024 | May 2025 | Allow | 13 | 0 | 0 | Yes | No |
| 18642853 | Device and Method for Deflecting and Focusing Shock Waves by a Reflection Surfaces with a Focal Point Different than a Projectile of a Thrust Direction of an Applicator | April 2024 | June 2025 | Allow | 14 | 1 | 0 | Yes | No |
| 18429958 | INTRAVASCULAR IMAGING CATHETER SYSTEM WITH FORCE ERROR DETECTION AND AUTOMATIC REMEDIATION VIA PULLBACK AND ROTATION | February 2024 | May 2025 | Allow | 15 | 0 | 0 | Yes | No |
| 18532371 | FOCUSED ULTRASOUND FOR RELIEVING PAIN AND SWELLING IN SKIN TREATMENT USING ELECTRIC MUSCLE STIMULATION AND COOLING | December 2023 | February 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18115075 | RELEASABLE PORTABLE IMAGING DEVICE FOR MULTISPECTRAL MOBILE TISSUE ASSESSMENT VIA DETERMINING DRIVING INTENSITY CORRECTION FOR LEDS | February 2023 | September 2024 | Allow | 18 | 2 | 1 | Yes | No |
| 18175485 | OPTICAL SURGICAL SYSTEM HAVING LIGHT EMITTERS AND LIGHT SENSORS COUPLED TO A CONTROLLER CONFIGURED TO REMOVE ANGULAR DISTORTION VIA COMPARISON OF ILLUMINATION PATTERNS | February 2023 | May 2024 | Allow | 15 | 0 | 0 | No | No |
| 18166589 | ABLATION AND IMAGING CATHETER WITH USER INTERFACE TO CATALOGUE ABLATION PARAMTERS AND IDENTIFICATION LABELS FOR LESIONS | February 2023 | June 2025 | Allow | 28 | 3 | 1 | Yes | No |
| 18058603 | IDENTIFYING A DEMENTIA BASED ON GAZE INFORMATION OF USER PERFORMING TASK ON A SCREEN AND GAZE TASK SCORE | November 2022 | February 2024 | Allow | 15 | 2 | 0 | Yes | No |
| 17960337 | Blood Pressure Tracking and Detection System | October 2022 | December 2023 | Allow | 14 | 2 | 0 | Yes | No |
| 17880951 | HIGH SPEED ULTRASONIC THICK SLICE IMAGING BY COMBINING SLICE IMAGES WITH MICROBEAMFORMER PROVIDED IN THE PROBE TO CONTROL STEERING | August 2022 | January 2024 | Allow | 17 | 0 | 0 | No | No |
| 17856487 | DIAGNOSTIC METHOD AND SYSTEM WITH OPTICAL AND TEMPERATURE SENSORS FOR IMAGING AND MAPPING FLUORESCENCE INTENSITIES OF TISSUE | July 2022 | October 2024 | Allow | 28 | 1 | 0 | Yes | No |
| 17838106 | IMAGE PROCESSING METHOD AND APPARATUS BASED ON CONTRAST-ENHANCED ULTRASOUND IMAGES TO IMPROVE SPATIAL SPARSITY OF MICROBUBBLES | June 2022 | June 2025 | Allow | 36 | 0 | 0 | Yes | No |
| 17686112 | Electromagnetic Tracking and Position Measurement System having Interference Reduction from Nearby Instrumentation by Filtering Time-Division Multiplexed Signal via Step Function | March 2022 | August 2024 | Allow | 30 | 2 | 0 | Yes | No |
| 17676000 | Method for detecting cancerous mass of breast via infrared by computer controlled motor for emitter and detector with collimator and window | February 2022 | July 2024 | Allow | 29 | 1 | 0 | Yes | No |
| 17457334 | DISPLACEMENT MECHANISM FOR PATIENT CONTROLLED PLACEMENT AND REMOVAL OF AN OPTICAL DEVICE IN A CONFINED SPACE ENVIRONMENT | December 2021 | January 2025 | Allow | 38 | 2 | 1 | Yes | No |
| 17534696 | OPTICAL TRACKING SYSTEM FOR TRACKING A PATIENT AND A SURGICAL INSTRUMENT WITH A REFERENCE MARKER AND SHAPE MEASUREMENT DEVICE VIA COORDINATE TRANSFORMATION | November 2021 | April 2024 | Allow | 29 | 0 | 0 | No | No |
| 17532838 | TRI-AXIAL SEISMOCARDIOGRAPHY DEVICES AND METHODS FOR MONITORING CARDIAC HEALTH AND IDENTIFYING A USER VIA CARDIAC FIDUCIARY MARKER MATCHING | November 2021 | February 2024 | Allow | 26 | 2 | 1 | Yes | No |
| 17474443 | DETERMINING A HEATING EFFECT OF A MRI SEQUENCE ON A DIAGNOSTIC MODALITY DUE TO THE TEMPERATURE VARIATIONS AND METHOD OF PREDICTING AND COMPENSATING THE VARIATIONS | September 2021 | June 2025 | Allow | 45 | 4 | 1 | Yes | No |
| 17462641 | REMOTE DETERMINATION OF ULTRASONIC CSF FLOWRATE IN VP SHUNT VIA MACHINE LEARNING AND ULTRASOUND FREQUENCY MATCHING | August 2021 | April 2024 | Allow | 32 | 1 | 1 | Yes | No |
| 17396272 | Method to Detect Perfusion and Brain Functional Activities Using Hyperpolarized 129Xe MRI | August 2021 | May 2025 | Abandon | 45 | 0 | 1 | No | No |
| 17381376 | ULTRASOUND ENDOSCOPE FOR PREVENTING A NON-COAXIAL CABLE FROM BEING DISCONNECTED AND IMPROVING A DEGREE OF FREEDOM OF WIRING | July 2021 | December 2024 | Allow | 41 | 4 | 0 | Yes | No |
| 17356558 | SCANNED LASER VEIN CONTRAST ENHANCER WITH REDUCED LASER INTENSITY DURING SCAN LINE REVERSALS | June 2021 | September 2024 | Allow | 39 | 1 | 1 | Yes | No |
| 17345392 | Magnetic Tracking Calibration via Distortion Correction for Electromagnetic Fields Using Inside-Out Tracking | June 2021 | December 2024 | Allow | 42 | 2 | 1 | Yes | No |
| 17194599 | Surgical Monitoring System and Related Methods For Spinal Pedicle Screw Alignment | March 2021 | July 2024 | Abandon | 40 | 1 | 1 | Yes | No |
| 17193318 | DEVICES, METHODS, AND SYSTEMS WITH SPECTRAL FILTERING FOR DETECTING WOUND AND IDENTIFYING BACTERIA BASED ON FLUORESCENCE SIGNATURE | March 2021 | October 2024 | Allow | 43 | 7 | 1 | Yes | Yes |
| 17249321 | DISTRIBUTED EXTRAVASATION DETECTION SYSTEM FOR FLUID CHANGE AND TO CONTROL THE FLUIDS LEVELS IN A BODY VIA WIRELESS INTERFACE BASED ON RATE OF ACTIVATION. | February 2021 | January 2024 | Allow | 35 | 1 | 1 | Yes | No |
| 17179429 | SYSTEMS AND METHODS FOR DIAGNOSIS AND IMAGE GUIDED THERAPY WITH SUPERCONDUCTING MAGNET SHIELDING AND PROVIDING HEAT EXCHANGE | February 2021 | January 2025 | Allow | 47 | 4 | 0 | Yes | No |
| 17072428 | INTEGRATED EXTRAVASATION AND INFILTRATION DETECTION DEVICE ON A RF ISOLATED FLEXIBLE SUBSTRATE WITH FLUID GUIDE TO DETECT FLUID CHANGES VIA SIGNAL COMPARISON | October 2020 | September 2023 | Allow | 35 | 1 | 1 | Yes | No |
| 17070993 | System and Method for Machine Learning based Mapping function of Patient Data from One Physiological State to Another Based on Computational Fluid Dynamics Simulation of Blood via Offline Training | October 2020 | July 2024 | Allow | 45 | 3 | 1 | Yes | No |
| 17031974 | COLLOCATED PET AND MRI ATTENUATION MAP ESTIMATION FOR RF COILS ATTENUATION CORRECTION VIA MACHINE LEARNING | September 2020 | February 2025 | Allow | 52 | 5 | 0 | Yes | No |
| 16989679 | Method and System for Personalized Treatment Planning in Ablation of Cancerous Tissue | August 2020 | May 2025 | Abandon | 58 | 4 | 0 | Yes | No |
| 16927911 | ENHANCED STETHOSCOPE DEVICE AND METHOD FOR BLOOD PRESSURE MEASUREMENT VIA PLURALITY OF ULTRASOUND TRANSDUCERS AND OPTICAL SENSORS TO DETERMINE TIME SERIES BLOOD VALUES USING AUTOENCODERS | July 2020 | February 2024 | Allow | 43 | 3 | 1 | Yes | No |
| 16868663 | WIRELESS AND POWER-SOURCE-FREE EXTRAVASATION AND INFILTRATION DETECTION SENSOR CIRCUITRY PROVIDED ON A SUBSTRATE WITH SIGNAL SPLITTER | May 2020 | September 2023 | Allow | 40 | 1 | 1 | Yes | No |
| 16759573 | COGNITIVE FUNCTION EVALUATION SYSTEM, METHOD, AND STORAGE MEDIUM FOR DEMENTIA BY ANALYZING VOICE OF EVALUATEE FOR RECOGNITION, REMEMBERING OR JUGMENT CAPABILITIES | April 2020 | December 2023 | Allow | 44 | 3 | 0 | Yes | No |
| 16649319 | METHODS AND SYSTEMS FOR RANDOM NOISE SUPRESSION AND FILTERING OF ACOUSTIC CLUTTER VIA AUTOREGRESSIVE MOVING AVERAGE FILTER | March 2020 | April 2025 | Allow | 60 | 5 | 0 | Yes | No |
| 16673335 | SYSTEM TO MONITOR AND MANAGE PATIENT HYDRATION VIA PLETHYSMOGRAPH VARIABLITY INDEX IN RESPONSE TO THE PASSIVE LEG RAISING | November 2019 | February 2024 | Allow | 51 | 3 | 1 | Yes | No |
| 16597656 | SYSTEM AND METHOD OF NONINVASIVE BLOOD FLOW MEASUREMENT DURING CARDIOPULMONARY RESUSCITATION USING SIGNAL GATING | October 2019 | September 2024 | Allow | 60 | 3 | 1 | Yes | No |
| 16577996 | SYSTEMS AND METHODS FOR TRANSDERMALLY DETECTING TISSUE ISCHEMIA AND EVALUATING ORGAN FUNCTION USING SERUM LUMINESCENCE | September 2019 | December 2024 | Allow | 60 | 3 | 1 | Yes | No |
| 16470678 | SHORT WAVE INFRARED BEDSIDE OR INTRA OPERATIVE ASSESSMENT OF WOUND OR BURN DEPTH AT DRY-WET LAYERS AND READINESS FOR RECONSTRUCTION | June 2019 | October 2024 | Allow | 60 | 4 | 1 | Yes | No |
| 16376691 | MAMMOGRAPHY-APPARATUS AND METHOD OF MEASURING A CONTACT AREA BETWEEN A BREAST AND THE MAMMOGRAPHY-APPARATUS | April 2019 | May 2024 | Abandon | 60 | 3 | 0 | No | No |
| 16371878 | MEDICAL IMAGE DIAGNOSTIC APPARATUS AND MEDICAL IMAGE DISPLAY APPARATUS FOR MRI or X-RAY CT VOLUME IMAGE CORRELATIONS | April 2019 | March 2024 | Allow | 59 | 3 | 1 | Yes | No |
| 16272616 | METHODS FOR IN VIVO FUNDUS MONOCHROMOTIC ANGIOGRAPHY IMAGING BLOOD-CONTAINING TISSUE BY UTILIZING TWO WAVELENGTH FROM 400NM TO 620 NM AND 620 NM TO 800 NM | February 2019 | October 2023 | Allow | 56 | 2 | 1 | Yes | No |
| 16254640 | FLEXIBLE SKIN THERAPY DEVICE HAVING PHOSPHORUS MATERIAL WITH LIGHT AND TRANSPARENT ELECTRICAL STIMULATION LAYERS | January 2019 | April 2024 | Allow | 60 | 3 | 1 | Yes | No |
| 16315390 | SYSTEMS AND METHODS FOR DETECTING EDEMA BY FUSING HYPERSPECTRAL AND VISIBLE IMAGE | January 2019 | May 2024 | Allow | 60 | 4 | 1 | Yes | No |
| 16131603 | Intravascular Imaging Catheter System with Force Error Detection and Automatic Remediation via Pullback and Rotation for Translating and Rotating a Torque Cable in a Catheter | September 2018 | October 2023 | Allow | 60 | 4 | 0 | Yes | No |
| 16034678 | PUNCTURE SUPPORT DEVICE FOR DETERMINING SAFE LINEAR PUNCTURE ROUTES BY PUNCTURE REGION CLASSIFICATION AND SUPERIMPOSING OF IMAGES | July 2018 | August 2023 | Allow | 60 | 4 | 0 | No | No |
| 15727266 | SYSTEM AND METHOD FOR ROBOTIC SURGICAL INTERVENTION IN A MAGNETIC RESONANCE IMAGER | October 2017 | November 2022 | Abandon | 60 | 2 | 1 | No | Yes |
| 15718835 | Stent Planning Systems and Methods Using Vessel Representation obtained via Intravascular Probe by Determining Stent Effectiveness Score and Fractional Flow Reserve | September 2017 | September 2023 | Allow | 60 | 5 | 1 | Yes | No |
| 14349333 | MAGNETIC RESONANCE IMAGING GUIDED BRACHYTHERAPY WITH DISPLAYING THE CATHETER PLACEMENT POSITION | April 2014 | November 2018 | Allow | 55 | 2 | 0 | No | Yes |
| 14115527 | METHOD AND APPARATUS FOR AUTOMATED DETERMINATION OF STENT LANDING ZONES BASED ON A MAXIMUM DIAMETER OF A SEGMENTED BLOOD VESSEL DATA OBTAINED BY INTRAVASCULAR DEVICE | November 2013 | October 2023 | Allow | 60 | 8 | 1 | No | No |
| 14008016 | CONTACTLESS SLEEP DISORDER SCREENING SYSTEM | October 2013 | September 2018 | Allow | 60 | 5 | 0 | No | No |
| 13796710 | Blood Vessel Lumen Morphology and Minimum Lumen Area Measurements Data Collection by Intravascular Imaging Systems for Stenosis or Stent Planning | March 2013 | August 2023 | Allow | 60 | 10 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner AKAR, SERKAN.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner AKAR, SERKAN works in Art Unit 3797 and has examined 49 patent applications in our dataset. With an allowance rate of 89.8%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 44 months.
Examiner AKAR, SERKAN's allowance rate of 89.8% places them in the 70% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by AKAR, SERKAN receive 2.76 office actions before reaching final disposition. This places the examiner in the 91% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by AKAR, SERKAN is 44 months. This places the examiner in the 3% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +24.9% benefit to allowance rate for applications examined by AKAR, SERKAN. This interview benefit is in the 75% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 32.5% of applications are subsequently allowed. This success rate is in the 61% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 4.8% of cases where such amendments are filed. This entry rate is in the 2% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 57.1% are granted (fully or in part). This grant rate is in the 73% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 44% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.